168 related articles for article (PubMed ID: 22066488)
1. Genome-wide screening and identification of antigens for rickettsial vaccine development.
Palmer GH; Brown WC; Noh SM; Brayton KA
FEMS Immunol Med Microbiol; 2012 Feb; 64(1):115-9. PubMed ID: 22066488
[TBL] [Abstract][Full Text] [Related]
2. Subdominant Outer Membrane Antigens in Anaplasma marginale: Conservation, Antigenicity, and Protective Capacity Using Recombinant Protein.
Ducken DR; Brown WC; Alperin DC; Brayton KA; Reif KE; Turse JE; Palmer GH; Noh SM
PLoS One; 2015; 10(6):e0129309. PubMed ID: 26079491
[TBL] [Abstract][Full Text] [Related]
3. Identification of Anaplasma marginale outer membrane protein antigens conserved between A. marginale sensu stricto strains and the live A. marginale subsp. centrale vaccine.
Agnes JT; Brayton KA; LaFollett M; Norimine J; Brown WC; Palmer GH
Infect Immun; 2011 Mar; 79(3):1311-8. PubMed ID: 21189322
[TBL] [Abstract][Full Text] [Related]
4. Subdominant antigens in bacterial vaccines: AM779 is subdominant in the Anaplasma marginale outer membrane vaccine but does not associate with protective immunity.
Albarrak SM; Brown WC; Noh SM; Reif KE; Scoles GA; Turse JE; Norimine J; Ueti MW; Palmer GH
PLoS One; 2012; 7(9):e46372. PubMed ID: 23029498
[TBL] [Abstract][Full Text] [Related]
5. Identification of novel antigenic proteins in a complex Anaplasma marginale outer membrane immunogen by mass spectrometry and genomic mapping.
Lopez JE; Siems WF; Palmer GH; Brayton KA; McGuire TC; Norimine J; Brown WC
Infect Immun; 2005 Dec; 73(12):8109-18. PubMed ID: 16299305
[TBL] [Abstract][Full Text] [Related]
6. Multistrain genome analysis identifies candidate vaccine antigens of Anaplasma marginale.
Dark MJ; Al-Khedery B; Barbet AF
Vaccine; 2011 Jul; 29(31):4923-32. PubMed ID: 21596083
[TBL] [Abstract][Full Text] [Related]
7. High-throughput identification of T-lymphocyte antigens from Anaplasma marginale expressed using in vitro transcription and translation.
Lopez JE; Beare PA; Heinzen RA; Norimine J; Lahmers KK; Palmer GH; Brown WC
J Immunol Methods; 2008 Mar; 332(1-2):129-41. PubMed ID: 18243240
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity of Anaplasma marginale type IV secretion system proteins in a protective outer membrane vaccine.
Lopez JE; Palmer GH; Brayton KA; Dark MJ; Leach SE; Brown WC
Infect Immun; 2007 May; 75(5):2333-42. PubMed ID: 17339347
[TBL] [Abstract][Full Text] [Related]
9. Identification of a T-Cell Epitope That Is Globally Conserved among Outer Membrane Proteins (OMPs) OMP7, OMP8, and OMP9 of Anaplasma marginale Strains and with OMP7 from the A. marginale subsp. centrale Vaccine Strain.
Deringer JR; Forero-Becerra EG; Ueti MW; Turse JE; Futse JE; Noh SM; Palmer GH; Brown WC
Clin Vaccine Immunol; 2017 Jan; 24(1):. PubMed ID: 27795302
[TBL] [Abstract][Full Text] [Related]
10. Anaplasma marginale outer membrane protein vaccine candidates are conserved in North American and South African strains.
Hove P; Brayton KA; Liebenberg J; Pretorius A; Oosthuizen MC; Noh SM; Collins NE
Ticks Tick Borne Dis; 2020 Jul; 11(4):101444. PubMed ID: 32336660
[TBL] [Abstract][Full Text] [Related]
11. Selection for simple major surface protein 2 variants during Anaplasma marginale transmission to immunologically naïve animals.
Palmer GH; Futse JE; Leverich CK; Knowles DP; Rurangirwa FR; Brayton KA
Infect Immun; 2007 Mar; 75(3):1502-6. PubMed ID: 17178787
[TBL] [Abstract][Full Text] [Related]
12. Protective immunity induced by immunization with a live, cultured Anaplasma marginale strain.
Hammac GK; Ku PS; Galletti MF; Noh SM; Scoles GA; Palmer GH; Brayton KA
Vaccine; 2013 Aug; 31(35):3617-22. PubMed ID: 23664994
[TBL] [Abstract][Full Text] [Related]
13. Expression of major surface protein 2 variants with conserved T-cell epitopes in Anaplasma centrale vaccinates.
Shkap V; Molad T; Brayton KA; Brown WC; Palmer GH
Infect Immun; 2002 Feb; 70(2):642-8. PubMed ID: 11796593
[TBL] [Abstract][Full Text] [Related]
14. Immunogenicity of hypothetical highly conserved proteins as novel antigens in Anaplasma marginale.
Nuñez PA; Moretta R; Ruybal P; Wilkowsky S; Farber MD
Curr Microbiol; 2014 Mar; 68(3):269-77. PubMed ID: 24126603
[TBL] [Abstract][Full Text] [Related]
15. Anaplasma marginale superinfection attributable to pathogen strains with distinct genomic backgrounds.
Vallejo Esquerra E; Herndon DR; Alpirez Mendoza F; Mosqueda J; Palmer GH
Infect Immun; 2014 Dec; 82(12):5286-92. PubMed ID: 25287920
[TBL] [Abstract][Full Text] [Related]
16. IgG and IgG2 antibodies from cattle naturally infected with Anaplasma marginale recognize the recombinant vaccine candidate antigens VirB9, VirB10, and elongation factor-Tu.
Araújo FR; Costa CM; Ramos CA; Farias TA; Souza II; Melo ES; Elisei C; Rosinha GM; Soares CO; Fragoso SP; Fonseca AH
Mem Inst Oswaldo Cruz; 2008 Mar; 103(2):186-90. PubMed ID: 18425271
[TBL] [Abstract][Full Text] [Related]
17. Linkage between Anaplasma marginale outer membrane proteins enhances immunogenicity but is not required for protection from challenge.
Noh SM; Turse JE; Brown WC; Norimine J; Palmer GH
Clin Vaccine Immunol; 2013 May; 20(5):651-6. PubMed ID: 23446216
[TBL] [Abstract][Full Text] [Related]
18. Rapid and long-term disappearance of CD4+ T lymphocyte responses specific for Anaplasma marginale major surface protein-2 (MSP2) in MSP2 vaccinates following challenge with live A. marginale.
Abbott JR; Palmer GH; Kegerreis KA; Hetrick PF; Howard CJ; Hope JC; Brown WC
J Immunol; 2005 Jun; 174(11):6702-15. PubMed ID: 15905510
[TBL] [Abstract][Full Text] [Related]
19. Molecular conservation of MSP4 and MSP5 in Anaplasma marginale and A. centrale vaccine strain.
Molad T; Brayton KA; Palmer GH; Michaeli S; Shkap V
Vet Microbiol; 2004 May; 100(1-2):55-64. PubMed ID: 15135513
[TBL] [Abstract][Full Text] [Related]
20. Differential expression and sequence conservation of the Anaplasma marginale msp2 gene superfamily outer membrane proteins.
Noh SM; Brayton KA; Knowles DP; Agnes JT; Dark MJ; Brown WC; Baszler TV; Palmer GH
Infect Immun; 2006 Jun; 74(6):3471-9. PubMed ID: 16714578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
